Insider Trades115 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Sell | INCY | Mohamed Khairie Issa | EVP, Head of U.S. Commercial | 1,099 | $115.09 | $23.4B | -1.96% | +74.56% | $126.5K | -1.66% | — | Stalk |
| Jul 14, 2026 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 1,790 | $115.01 | $23.4B | -1.96% | +74.56% | $205.9K | -4.41% | — | Stalk |
| Jul 14, 2026 | Sell | INCY | Patrick A Mayes | EVP & Chief Scientific Officer | 1,949 | $115.04 | $23.4B | -1.96% | +74.56% | $224.2K | -1.64% | — | Stalk |
| Jul 14, 2026 | Sell | INCY | Pablo J Cagnoni | President, Global Head of R&D | 22,919 | $114.93 | $23.4B | -1.96% | +74.56% | $2.6M | -4.94% | — | Stalk |
| Jul 14, 2026 | Sell | INCY | Steven H Stein | CMO & Head of Late-Stage Dev. | 53,155 | $113.92 | $23.4B | -1.96% | +74.56% | $6.1M | -33.95% | — | Stalk |
| Jul 2, 2026 | Sell | INCY | Patrick A Mayes | EVP & Chief Scientific Officer | 350 | $116.86 | $23.4B | -1.96% | +74.56% | $40.9K | -0.58% | — | Stalk |
| Jul 2, 2026 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 477 | $116.86 | $23.4B | -1.96% | +74.56% | $55.7K | -2.26% | — | Stalk |
| Jul 2, 2026 | Sell | INCY | Steven H Stein | CMO & Head of Late-Stage Dev. | 2,177 | $116.86 | $23.4B | -1.96% | +74.56% | $254.4K | -2.78% | — | Stalk |
| Jul 2, 2026 | Sell | INCY | William Meury | Chief Executive Officer | 4,779 | $116.86 | $23.4B | -1.96% | +74.56% | $558.5K | -2.97% | — | Stalk |
| Jun 4, 2026 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 5,278 | $91.91 | $23.4B | -1.96% | +74.56% | $485.1K | +0.00% | — | Stalk |
| Jun 1, 2026 | Sell | INCY | Pablo J Cagnoni | President, Global Head of R&D | 25,469 | $95.59 | $23.4B | -1.96% | +74.56% | $2.4M | -9.56% | — | Stalk |
| May 26, 2026 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 2,051 | $97.35 | $23.4B | -1.96% | +74.56% | $199.7K | -8.85% | — | Stalk |
| Apr 17, 2026 | Sell | INCY | Pablo J Cagnoni | President, Global Head of R&D | 37,334 | $82.96 | $23.4B | -1.96% | +74.56% | $3.1M | +0.00% | — | Stalk |
| Mar 25, 2026 | Sell | INCY | Matteo Trotta | EVP, GM, Dermatology US | 537 | $92.23 | $23.4B | -1.96% | +74.56% | $49.5K | -3.48% | — | Stalk |
| Mar 17, 2026 | Sell | INCY | Pablo J Cagnoni | President, R&D | 37,334 | $78.66 | $23.4B | -1.96% | +74.56% | $2.9M | +0.00% | — | Stalk |
| Feb 19, 2026 | Sell | INCY | Pablo J Cagnoni | President, R&D | 37,336 | $81.25 | $23.4B | -1.96% | +74.56% | $3.0M | +0.00% | — | Stalk |
| Feb 2, 2026 | Sell | INCY | Lee Heeson | EVP, Head of Incyte Intl | 111 | $102.67 | $23.4B | -1.96% | +74.56% | $11.4K | -0.29% | — | Stalk |
| Feb 2, 2026 | Sell | INCY | Michael James Morrissey | EVP, Head of Tech. Operations | 185 | $102.67 | $23.4B | -1.96% | +74.56% | $19.0K | -0.54% | — | Stalk |
| Jan 20, 2026 | Sell | INCY | Michael James Morrissey | EVP, Head of Tech. Operations | 429 | $102.62 | $23.4B | -1.96% | +74.56% | $44.0K | -1.24% | — | Stalk |
| Jan 6, 2026 | Sell | INCY | Mohamed Khairie Issa | EVP, Head of US Oncology | 19,120 | $108.03 | $23.4B | -1.96% | +74.56% | $2.1M | -11.79% | — | Stalk |
| Jan 5, 2026 | Sell | INCY | Steven H Stein | EVP & Chief Medical Officer | 15,634 | $101.70 | $23.4B | -1.96% | +74.56% | $1.6M | -31.37% | — | Stalk |
| Dec 31, 2025 | Sell | INCY | Michael James Morrissey | EVP, Head of Tech. Operations | 254 | $98.77 | $23.4B | -1.96% | +74.56% | $25.1K | -0.92% | — | Stalk |
| Dec 31, 2025 | Sell | INCY | Steven H Stein | EVP & Chief Medical Officer | 13,292 | $98.77 | $23.4B | -1.96% | +74.56% | $1.3M | -21.06% | — | Stalk |
| Dec 18, 2025 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 6,148 | $97.92 | $23.4B | -1.96% | +74.56% | $602.0K | -0.62% | — | Stalk |
| Dec 16, 2025 | Sell | INCY | Michael James Morrissey | EVP, Head of Tech. Operations | 58,331 | $97.29 | $23.4B | -1.96% | +74.56% | $5.7M | -28.78% | — | Stalk |
| Dec 10, 2025 | Sell | INCY | Patrick A Mayes | EVP & Chief Scientific Officer | 5,808 | $95.55 | $23.4B | -1.96% | +74.56% | $555.0K | -4.61% | — | Stalk |
| Dec 1, 2025 | Sell | INCY | Michael James Morrissey | EVP, Head of Tech. Operations | 326 | $102.04 | $23.4B | -1.96% | +74.56% | $33.3K | -0.38% | — | Stalk |
| Dec 1, 2025 | Sell | INCY | Steven H Stein | EVP & Chief Medical Officer | 39,757 | $102.34 | $23.4B | -1.96% | +74.56% | $4.1M | -13.88% | — | Stalk |
| Nov 21, 2025 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 769 | $102.78 | $23.4B | -1.96% | +74.56% | $79.0K | -1.59% | — | Stalk |
| Nov 17, 2025 | Sell | INCY | Sheila A. Denton | EVP & General Counsel | 556 | $84.31 | $23.4B | -1.96% | +74.56% | $46.9K | +0.00% | — | Stalk |
| Nov 5, 2025 | Sell | INCY | Steven H Stein | EVP & Chief Medical Officer | 10,466 | $97.62 | $23.4B | -1.96% | +74.56% | $1.0M | +0.00% | — | Stalk |
| Nov 4, 2025 | Sell | INCY | Sheila A. Denton | EVP & General Counsel | 1,196 | $79.71 | $23.4B | -1.96% | +74.56% | $95.3K | +0.00% | — | Stalk |
| Nov 3, 2025 | Sell | INCY | Lee Heeson | EVP, Head of Incyte Intl | 3,074 | $94.02 | $23.4B | -1.96% | +74.56% | $289.0K | -9.51% | — | Stalk |
| Oct 15, 2025 | Sell | INCY | Sheila A. Denton | EVP & General Counsel | 554 | $74.69 | $23.4B | -1.96% | +74.56% | $41.4K | +0.00% | — | Stalk |
| Oct 2, 2025 | Sell | INCY | Sheila A. Denton | EVP & General Counsel | 7,829 | $83.89 | $23.4B | -1.96% | +74.56% | $656.8K | -4.58% | — | Stalk |
| Oct 1, 2025 | Sell | INCY | Lee Heeson | EVP, Head of Incyte Intl | 463 | $86.70 | $23.4B | -1.96% | +74.56% | $40.1K | -1.41% | — | Stalk |
| Oct 1, 2025 | Sell | INCY | Patrick A Mayes | EVP & Chief Scientific Officer | 1,569 | $86.70 | $23.4B | -1.96% | +74.56% | $136.0K | -2.33% | — | Stalk |
| Sep 16, 2025 | Sell | INCY | Sheila A. Denton | EVP & General Counsel | 556 | $73.70 | $23.4B | -1.96% | +74.56% | $41.0K | +0.00% | — | Stalk |
| Sep 2, 2025 | Sell | INCY | Sheila A. Denton | EVP & General Counsel | 1,196 | $71.52 | $23.4B | -1.96% | +74.56% | $85.5K | +0.00% | — | Stalk |
| Aug 15, 2025 | Sell | INCY | Sheila A. Denton | EVP & General Counsel | 554 | $75.53 | $23.4B | -1.96% | +74.56% | $41.8K | +0.00% | — | Stalk |
| Aug 4, 2025 | Sell | INCY | Sheila A. Denton | EVP & General Counsel | 1,196 | $66.91 | $23.4B | -1.96% | +74.56% | $80.0K | +0.00% | — | Stalk |
| Jul 21, 2025 | Sell | INCY | Steven H Stein | EVP & Chief Medical Officer | 3,706 | $67.94 | $23.4B | -1.96% | +74.56% | $251.8K | -3.48% | — | Stalk |
| Jul 16, 2025 | Sell | INCY | Vijay K Iyengar | EVP, GMAPPS | 983 | $68.36 | $23.4B | -1.96% | +74.56% | $67.2K | -2.37% | — | Stalk |
| Jul 16, 2025 | Sell | INCY | Barry P Flannelly | EVP & General Manager US | 1,340 | $68.36 | $23.4B | -1.96% | +74.56% | $91.6K | -3.67% | — | Stalk |
| Jul 15, 2025 | Sell | INCY | Matteo Trotta | EVP, GM, Dermatology US | 182 | $68.25 | $23.4B | -1.96% | +74.56% | $12.4K | -0.52% | — | Stalk |
| Jul 15, 2025 | Sell | INCY | Sheila A. Denton | EVP & General Counsel | 8,148 | $67.28 | $23.4B | -1.96% | +74.56% | $548.2K | -0.90% | — | Stalk |
| Jul 14, 2025 | Sell | INCY | Paula J Swain | EVP, Human Resources | 1,007 | $69.01 | $23.4B | -1.96% | +74.56% | $69.5K | -0.43% | — | Stalk |
| Jul 14, 2025 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 1,275 | $69.19 | $23.4B | -1.96% | +74.56% | $88.2K | -2.84% | — | Stalk |
| Jul 14, 2025 | Sell | INCY | Vijay K Iyengar | EVP, GMAPPS | 2,608 | $69.37 | $23.4B | -1.96% | +74.56% | $180.9K | -1.85% | — | Stalk |
| Jul 14, 2025 | Sell | INCY | Christiana Stamoulis | EVP & Chief Financial Officer | 2,852 | $69.10 | $23.4B | -1.96% | +74.56% | $197.1K | -1.00% | — | Stalk |
| Jul 14, 2025 | Sell | INCY | Barry P Flannelly | EVP & General Manager US | 3,255 | $69.33 | $23.4B | -1.96% | +74.56% | $225.7K | -2.80% | — | Stalk |
| Jul 14, 2025 | Sell | INCY | Pablo J Cagnoni | President, R&D | 3,908 | $68.82 | $23.4B | -1.96% | +74.56% | $268.9K | -0.75% | — | Stalk |
| Jul 14, 2025 | Sell | INCY | Herve Hoppenot | Special Advisor to the CEO | 9,674 | $69.14 | $23.4B | -1.96% | +74.56% | $668.8K | -0.92% | — | Stalk |
| Jul 14, 2025 | Sell | INCY | Steven H Stein | EVP & Chief Medical Officer | 18,103 | $68.58 | $23.4B | -1.96% | +74.56% | $1.2M | -4.97% | — | Stalk |
| Jul 2, 2025 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 897 | $68.17 | $23.4B | -1.96% | +74.56% | $61.1K | -4.08% | — | Stalk |
| Jul 2, 2025 | Sell | INCY | Sheila A. Denton | EVP & General Counsel | 1,198 | $63.34 | $23.4B | -1.96% | +74.56% | $75.9K | +0.00% | — | Stalk |
| Jul 2, 2025 | Sell | INCY | Paula J Swain | EVP, Human Resources | 6,285 | $68.17 | $23.4B | -1.96% | +74.56% | $428.4K | -5.86% | — | Stalk |
| Jul 2, 2025 | Sell | INCY | Christiana Stamoulis | EVP & Chief Financial Officer | 11,589 | $68.17 | $23.4B | -1.96% | +74.56% | $790.0K | -8.98% | — | Stalk |
| Jul 2, 2025 | Sell | INCY | Steven H Stein | EVP & Chief Medical Officer | 12,714 | $68.17 | $23.4B | -1.96% | +74.56% | $866.7K | -10.16% | — | Stalk |
| Jul 2, 2025 | Sell | INCY | Vijay K Iyengar | EVP, GMAPPS | 15,426 | $68.16 | $23.4B | -1.96% | +74.56% | $1.1M | -10.78% | — | Stalk |
| Jul 2, 2025 | Sell | INCY | Barry P Flannelly | EVP & General Manager US | 19,958 | $68.16 | $23.4B | -1.96% | +74.56% | $1.4M | -18.09% | — | Stalk |
| Jul 2, 2025 | Sell | INCY | Herve Hoppenot | Special Advisor to the CEO | 42,769 | $68.17 | $23.4B | -1.96% | +74.56% | $2.9M | -7.51% | — | Stalk |
| Jun 3, 2025 | Sell | INCY | Sheila A. Denton | EVP & General Counsel | 3,590 | $63.03 | $23.4B | -1.96% | +74.56% | $226.3K | +0.00% | — | Stalk |
| May 30, 2025 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 1,614 | $65.38 | $23.4B | -1.96% | +74.56% | $105.5K | -3.49% | — | Stalk |
| Mar 25, 2025 | Sell | INCY | Matteo Trotta | EVP, GM, Dermatology US | 537 | $62.08 | $23.4B | -1.96% | +74.56% | $33.3K | -5.13% | — | Stalk |
| Mar 14, 2025 | Sell | INCY | Barry P Flannelly | EVP & General Manager US | 19,807 | $67.69 | $23.4B | -1.96% | +74.56% | $1.3M | -12.46% | — | Stalk |
| Mar 4, 2025 | Sell | INCY | Sheila A. Denton | EVP & General Counsel | 1,198 | $64.02 | $23.4B | -1.96% | +74.56% | $76.7K | +0.00% | — | Stalk |
| Feb 26, 2025 | Sell | INCY | Sheila A. Denton | EVP & General Counsel | 23,643 | $67.59 | $23.4B | -1.96% | +74.56% | $1.6M | -3.75% | — | Stalk |
| Jan 21, 2025 | Sell | INCY | Michael James Morrissey | EVP, Head of Tech. Operations | 429 | $73.47 | $23.4B | -1.96% | +74.56% | $31.5K | -0.60% | — | Stalk |
| Jan 21, 2025 | Sell | INCY | Steven H Stein | EVP & Chief Medical Officer | 12,352 | $72.69 | $23.4B | -1.96% | +74.56% | $897.9K | -11.49% | — | Stalk |
| Jan 15, 2025 | Sell | INCY | Michael James Morrissey | EVP, Head of Tech. Operations | 908 | $72.46 | $23.4B | -1.96% | +74.56% | $65.8K | -1.26% | — | Stalk |
| Jan 15, 2025 | Sell | INCY | Barry P Flannelly | EVP & General Manager US | 3,158 | $72.46 | $23.4B | -1.96% | +74.56% | $228.8K | -5.59% | — | Stalk |
| Jan 15, 2025 | Sell | INCY | Christiana Stamoulis | EVP & Chief Financial Officer | 3,672 | $72.46 | $23.4B | -1.96% | +74.56% | $266.1K | -3.86% | — | Stalk |
| Jan 15, 2025 | Sell | INCY | Steven H Stein | EVP & Chief Medical Officer | 10,692 | $72.46 | $23.4B | -1.96% | +74.56% | $774.7K | -11.88% | — | Stalk |
| Dec 13, 2024 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 1,300 | $69.97 | $23.4B | -1.96% | +74.56% | $91.0K | -2.68% | — | Stalk |
| Dec 9, 2024 | Sell | INCY | Paula J Swain | EVP, Human Resources | 873 | $72.11 | $23.4B | -1.96% | +74.56% | $63.0K | -1.01% | — | Stalk |
| Dec 9, 2024 | Sell | INCY | Barry P Flannelly | EVP & General Manager US | 1,510 | $72.11 | $23.4B | -1.96% | +74.56% | $108.9K | -2.60% | — | Stalk |
| Nov 29, 2024 | Sell | INCY | Vijay K Iyengar | EVP, GMAPPS | 6,043 | $75.38 | $23.4B | -1.96% | +74.56% | $455.5K | -8.27% | — | Stalk |
| Nov 6, 2024 | Sell | INCY | Barry P Flannelly | EVP & General Manager US | 7,360 | $74.85 | $23.4B | -1.96% | +74.56% | $550.9K | +0.00% | — | Stalk |
| Oct 2, 2024 | Sell | INCY | Sheila A. Denton | EVP & General Counsel | 2,136 | $67.63 | $23.4B | -1.96% | +74.56% | $144.5K | -6.58% | — | Stalk |
| Sep 12, 2024 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 954 | $63.11 | $23.4B | -1.96% | +74.56% | $60.2K | -1.90% | — | Stalk |
| Sep 12, 2024 | Sell | INCY | Jonathan Elliott Dickinson | EVP, General Manager, Europe | 8,450 | $62.36 | $23.4B | -1.96% | +74.56% | $526.9K | -9.54% | — | Stalk |
| Aug 12, 2024 | Sell | INCY | Steven H Stein | EVP & Chief Medical Officer | 11,608 | $60.63 | $23.4B | -1.96% | +74.56% | $703.8K | -11.42% | — | Stalk |
| Jul 25, 2024 | Sell | INCY | Vijay K Iyengar | EVP, GMAPPS | 15,571 | $70.00 | $23.4B | -1.96% | +74.56% | $1.1M | -29.79% | — | Stalk |
| Jul 15, 2024 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 466 | $64.25 | $23.4B | -1.96% | +74.56% | $29.9K | -1.57% | — | Stalk |
| Jul 15, 2024 | Sell | INCY | Vijay K Iyengar | EVP, GMAPPS | 549 | $64.25 | $23.4B | -1.96% | +74.56% | $35.3K | -0.79% | — | Stalk |
| Jul 15, 2024 | Sell | INCY | Paula J Swain | EVP, Human Resources | 549 | $64.25 | $23.4B | -1.96% | +74.56% | $35.3K | -0.53% | — | Stalk |
| Jul 15, 2024 | Sell | INCY | Pablo J Cagnoni | President, R&D | 749 | $64.25 | $23.4B | -1.96% | +74.56% | $48.1K | -0.28% | — | Stalk |
| Jul 15, 2024 | Sell | INCY | Christiana Stamoulis | EVP & Chief Financial Officer | 948 | $64.25 | $23.4B | -1.96% | +74.56% | $60.9K | -0.76% | — | Stalk |
| Jul 15, 2024 | Sell | INCY | Steven H Stein | EVP & Chief Medical Officer | 1,555 | $64.25 | $23.4B | -1.96% | +74.56% | $99.9K | -1.16% | — | Stalk |
| Jul 15, 2024 | Sell | INCY | Barry P Flannelly | EVP & General Manager US | 2,417 | $64.22 | $23.4B | -1.96% | +74.56% | $155.2K | -1.70% | — | Stalk |
| Jul 15, 2024 | Sell | INCY | Herve Hoppenot | Chairman / CEO | 4,961 | $64.25 | $23.4B | -1.96% | +74.56% | $318.7K | -0.88% | — | Stalk |
| Jul 9, 2024 | Sell | INCY | Barry P Flannelly | EVP & General Manager US | 8,148 | $60.00 | $23.4B | -1.96% | +74.56% | $488.9K | -13.89% | — | Stalk |
| Jul 2, 2024 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 844 | $59.02 | $23.4B | -1.96% | +74.56% | $49.8K | -3.90% | — | Stalk |
| Jul 2, 2024 | Sell | INCY | Paula J Swain | EVP, Human Resources | 5,560 | $59.02 | $23.4B | -1.96% | +74.56% | $328.2K | -6.55% | — | Stalk |
| Jul 2, 2024 | Sell | INCY | Vijay K Iyengar | EVP, GMAPPS | 5,706 | $59.02 | $23.4B | -1.96% | +74.56% | $336.8K | -11.13% | — | Stalk |
| Jul 2, 2024 | Sell | INCY | Christiana Stamoulis | EVP & Chief Financial Officer | 6,870 | $59.02 | $23.4B | -1.96% | +74.56% | $405.5K | -7.60% | — | Stalk |
| Jul 2, 2024 | Sell | INCY | Barry P Flannelly | EVP & General Manager US | 7,695 | $59.02 | $23.4B | -1.96% | +74.56% | $454.2K | -11.59% | — | Stalk |
| Jul 2, 2024 | Sell | INCY | Steven H Stein | EVP & Chief Medical Officer | 8,316 | $59.02 | $23.4B | -1.96% | +74.56% | $490.8K | -8.52% | — | Stalk |
| Jul 2, 2024 | Sell | INCY | Herve Hoppenot | Chairman / CEO | 41,723 | $59.02 | $23.4B | -1.96% | +74.56% | $2.5M | -8.31% | — | Stalk |
| Jun 12, 2024 | Sell | INCY | Barry P Flannelly | EVP & General Manager US | 19,164 | $60.00 | $23.4B | -1.96% | +74.56% | $1.1M | -22.40% | — | Stalk |
| Jun 6, 2024 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 1,093 | $58.91 | $23.4B | -1.96% | +74.56% | $64.4K | -4.81% | — | Stalk |
| Feb 12, 2024 | Sell | INCY | Christiana Stamoulis | EVP & Chief Financial Officer | 387 | $57.84 | $23.4B | -1.96% | +74.56% | $22.4K | -0.47% | — | Stalk |
| Jan 22, 2024 | Sell | INCY | Jonathan Elliott Dickinson | EVP, General Manager, Europe | 108 | $61.50 | $23.4B | -1.96% | +74.56% | $6.6K | -0.24% | — | Stalk |
| Jan 22, 2024 | Sell | INCY | Michael James Morrissey | EVP, Head of Tech. Operations | 108 | $61.50 | $23.4B | -1.96% | +74.56% | $6.6K | -0.15% | — | Stalk |
| Jan 18, 2024 | Buy | INCY | Jonathan Elliott Dickinson | EVP, General Manager, Europe | 8,236 | $61.18 | $23.4B | -1.96% | +74.56% | $503.9K | +9.85% | — | Stalk |
| Jan 18, 2024 | Buy | INCY | Michael James Morrissey | EVP, Head of Tech. Operations | 11,481 | $61.18 | $23.4B | -1.96% | +74.56% | $702.4K | +8.40% | — | Stalk |
| Jan 17, 2024 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 1,021 | $61.48 | $23.4B | -1.96% | +74.56% | $62.8K | -3.65% | — | Stalk |
| Jan 17, 2024 | Sell | INCY | Barry P Flannelly | EVP & General Manager US | 3,675 | $61.48 | $23.4B | -1.96% | +74.56% | $225.9K | -4.52% | — | Stalk |
| Jan 16, 2024 | Sell | INCY | Michael James Morrissey | EVP, Head of Tech. Operations | 202 | $61.41 | $23.4B | -1.96% | +74.56% | $12.4K | -0.16% | — | Stalk |
| Jan 16, 2024 | Sell | INCY | Jonathan Elliott Dickinson | EVP, General Manager, Europe | 202 | $61.41 | $23.4B | -1.96% | +74.56% | $12.4K | -0.28% | — | Stalk |
| Jan 3, 2024 | Sell | INCY | Steven H Stein | EVP & Chief Medical Officer | 7,365 | $65.51 | $23.4B | -1.96% | +74.56% | $482.5K | -7.55% | — | Stalk |
| Jan 2, 2024 | Sell | INCY | Vijay K Iyengar | EVP, GMAPPS | 657 | $65.00 | $23.4B | -1.96% | +74.56% | $42.7K | -1.49% | — | Stalk |
| Dec 12, 2023 | Sell | INCY | Thomas Tray | Principal Accounting Officer | 1,277 | $61.55 | $23.4B | -1.96% | +74.56% | $78.6K | -2.59% | — | Stalk |
| Sep 1, 2023 | Sell | INCY | Paula J Swain | EVP, Human Resources | 8,449 | $65.13 | $23.4B | -1.96% | +74.56% | $550.3K | -9.83% | — | Stalk |